Impact of antiretroviral resistance and virological failure on HIV-1 informational entropy

被引:3
|
作者
de Carvalho Lima, Elidamar Nunes [1 ,2 ]
Castilho Piqueira, Jose Roberto [2 ]
Camargo, Michelle [1 ]
Galinskas, Juliana [1 ]
Sucupira, Maria Cecilia [1 ]
Diaz, Ricardo Sobhie [1 ]
机构
[1] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Div Infect Dis, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Sch Engn, Telecommun & Control Engn Dept, Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; T-LYMPHOCYTE EPITOPES; VIRAL FITNESS; REVERSE-TRANSCRIPTASE; SELECTION PRESSURE; PROTEASE; MUTATIONS; EVOLUTION; SYSTEMS;
D O I
10.1093/jac/dkx508
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The present study investigated the relationship between genomic variability and resistance of HIV-1 sequences in protease (PR) and reverse transcriptase (RT) regions of the pol gene. In addition, we analysed the resistance among 651 individuals presenting antiretroviral virological failure, from 2009 to 2011, in the state of Sao Paulo, Brazil. Methods: The genomic variability was quantified by using informational entropy methods and the relationship between resistance and replicative fitness, as inferred by the residual viral load and CD4+ T cell count. Results: The number of antiretroviral schemes is related to the number of resistance mutations in the HIV-1 PR (alpha = 0.2511, P = 0.0003, R-2 = 0.8672) and the RT (alpha = 0.7892, P = 0.0001, R-2 = 0.9141). Increased informational entropy rate is related to lower levels of HIV-1 viral loads (alpha = -0.0121, P = 0.0471, R-2 = 0.7923), lower levels of CD4+ T cell counts (alpha = -0.0120, P = 0.0335, R-2 = 0.8221) and a higher number of antiretroviral resistance-related mutations. Conclusions: Less organized HIV genomes as inferred by higher levels of informational entropy relate to less competent host immune systems, lower levels of HIV replication and HIV genetic evolution as a consequence of antiretroviral resistance.
引用
收藏
页码:1054 / 1059
页数:6
相关论文
共 50 条
  • [21] Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
    Ledergerber, B
    Egger, M
    Opravil, M
    Telenti, A
    Hirschel, B
    Battegay, M
    Vernazza, P
    Sudre, P
    Flepp, M
    Furrer, H
    Francioli, P
    Weber, R
    LANCET, 1999, 353 (9156): : 863 - 868
  • [22] Antiretroviral resistance in different HIV-1 subtypes: impact on therapy outcomes and resistance testing interpretation
    Camacho, Ricardo Jorge
    Vandamme, Anne-Mieke
    CURRENT OPINION IN HIV AND AIDS, 2007, 2 (02) : 123 - 129
  • [23] Antiretroviral Genotypic Resistance Mutations in HIV-1 Infected Korean Patients with Virologic Failure
    Chin, Bum Sik
    Choi, Ju-Yeon
    Choi, Jin Young
    Kim, Gab Jung
    Kee, Mee-Kyung
    Kim, June Myung
    Kim, Sung Soon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (06) : 1031 - 1037
  • [24] Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon
    Aghokeng, Avelin F.
    Kouanfack, Charles
    Eymard-Duvernay, Sabrina
    Butel, Christelle
    Edoul, Ginette E.
    Laurent, Christian
    Koulla-Shiro, Sinata
    Delaporte, Eric
    Mpoudi-Ngole, Eitel
    Peeters, Martine
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2013, 16
  • [25] Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study
    Costagliola, Dominique
    Lodwick, R.
    Ledergerber, B.
    Torti, C.
    van Sighem, A.
    Podzamczer, D.
    Mocroft, A.
    Dorrucci, M.
    Masquelier, B.
    de Luca, A.
    Jansen, K.
    De Wit, S.
    Obel, N.
    Fatkenheuer, G.
    Touloumi, G.
    Mussini, C.
    Castagna, A.
    Stephan, C.
    Garcia, F.
    Zangerle, R.
    Duval, X.
    Perez-Hoyos, S.
    Meyer, L.
    Ghosn, J.
    Fabre-Colin, C.
    Kjaer, J.
    Chene, G.
    Garup, J.
    Phillips, A.
    LANCET INFECTIOUS DISEASES, 2012, 12 (02): : 119 - 127
  • [26] HIV-1 drug resistance at virological failure versus immunological failure among patients failing first-line antiretroviral therapy in a resource-limited setting
    Sungkanuparph, S.
    Win, M. M.
    Kiertiburanakul, S.
    Phonrat, B.
    Maek-a-nantawat, W.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (05) : 316 - 318
  • [27] Current Perspectives on HIV-1 Antiretroviral Drug Resistance
    Iyidogan, Pinar
    Anderson, Karen S.
    VIRUSES-BASEL, 2014, 6 (10): : 4095 - 4139
  • [28] HIV-1 Subtypes and Primary Antiretroviral Resistance Mutations in Antiretroviral Therapy Naive HIV-1 Infected Individuals in Turkey
    Sayan, M.
    Willke, A.
    Ozgunes, N.
    Sargin, F.
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (04) : 306 - 311
  • [29] Clinical Implications of Genotypic Resistance to the Newer Antiretroviral Drugs in HIV-1-Infected Patients with Virological Failure
    Llibre, Josep M.
    Schapiro, Jonathan M.
    Clotet, Bonaventura
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (06) : 872 - 881
  • [30] The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens
    Maggiolo, Franco
    Ripamonti, Diego
    Torti, Carlo
    Arici, Claudio
    Antinori, Andrea
    Quiros-Roldan, Eugenia
    Minoli, Lorenzo
    Sighinolfi, Laura
    Nasta, Paolo
    Suter, Fredy
    ANTIVIRAL THERAPY, 2006, 11 (07) : 923 - 929